amiodarone: be contraindicated in cardiogenic shock

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.58
, medicine
Weight: 0.54
, agent
Weight: 0.45
, medication
Weight: 0.45
Siblings warfarin
Weight: 0.36
, vancomycin
Weight: 0.35
, acetaminophen
Weight: 0.35
, ibuprofen
Weight: 0.34
, metronidazole
Weight: 0.34

Related properties

Property Similarity
be contraindicated in cardiogenic shock 1.00
be contraindicated in shock 0.97
be contraindicated in heart blocks 0.89
be used in atrial fibrillation 0.76
be used in fibrillation 0.75
has state extravasation 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.04
Rule weight: 0.13
Evidence weight: 0.44
Similarity weight: 0.76
Evidence: 0.67
¬ Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.83
¬ Remarkable(warfarin, be used in atrial fibrillation)
0.04
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.75
Evidence: 0.67
¬ Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.89
¬ Remarkable(warfarin, be used in fibrillation)

Remarkability from sibling implausibility

0.44
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.75
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.89
Remarkable(warfarin, be used in fibrillation)
Evidence: 0.47
¬ Plausible(warfarin, be used in fibrillation)
0.44
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.83
Remarkable(warfarin, be used in atrial fibrillation)
Evidence: 0.58
¬ Plausible(warfarin, be used in atrial fibrillation)

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.56
¬ Salient(amiodarone, be contraindicated in cardiogenic shock)

Similarity expansion

0.65
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.97
Evidence: 0.67
Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.66
¬ Remarkable(amiodarone, be contraindicated in shock)
0.61
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.75
Evidence: 0.46
Typical(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.09
¬ Typical(amiodarone, be used in fibrillation)
0.60
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.89
Evidence: 0.67
Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.65
¬ Remarkable(amiodarone, be contraindicated in heart blocks)
0.57
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.46
Typical(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.24
¬ Typical(amiodarone, be used in atrial fibrillation)
0.55
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.75
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.28
¬ Plausible(amiodarone, be used in fibrillation)
0.55
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.97
Evidence: 0.56
Salient(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.78
¬ Salient(amiodarone, be contraindicated in shock)
0.53
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.75
Evidence: 0.67
Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.52
¬ Remarkable(amiodarone, has state extravasation)
0.53
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.97
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.68
¬ Plausible(amiodarone, be contraindicated in shock)
0.52
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.76
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.37
¬ Plausible(amiodarone, be used in atrial fibrillation)
0.52
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.89
Evidence: 0.56
Salient(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.70
¬ Salient(amiodarone, be contraindicated in heart blocks)
0.52
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.75
Evidence: 0.56
Salient(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.43
¬ Salient(amiodarone, has state extravasation)
0.52
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.97
Evidence: 0.46
Typical(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.70
¬ Typical(amiodarone, be contraindicated in shock)
0.51
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.89
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.61
¬ Plausible(amiodarone, be contraindicated in heart blocks)
0.51
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.75
Evidence: 0.56
Salient(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.48
¬ Salient(amiodarone, be used in fibrillation)
0.50
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.76
Evidence: 0.56
Salient(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.52
¬ Salient(amiodarone, be used in atrial fibrillation)
0.50
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.89
Evidence: 0.46
Typical(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.63
¬ Typical(amiodarone, be contraindicated in heart blocks)
0.50
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.75
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.43
¬ Plausible(amiodarone, has state extravasation)
0.48
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.75
Evidence: 0.46
Typical(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.46
¬ Typical(amiodarone, has state extravasation)
0.48
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.76
Evidence: 0.67
Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.82
¬ Remarkable(amiodarone, be used in atrial fibrillation)
0.45
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.75
Evidence: 0.67
Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.90
¬ Remarkable(amiodarone, be used in fibrillation)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.56
Salient(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.46
¬ Typical(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.67
¬ Remarkable(amiodarone, be contraindicated in cardiogenic shock)

Typical implies Plausible

0.36
Rule weight: 0.48
Evidence weight: 0.76
Similarity weight: 1.00
Evidence: 0.47
Plausible(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.46
¬ Typical(amiodarone, be contraindicated in cardiogenic shock)

Typicality and Rermarkability incompatibility between siblings

0.08
Rule weight: 0.14
Evidence weight: 0.80
Similarity weight: 0.75
Evidence: 0.67
¬ Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.29
¬ Typical(warfarin, be used in fibrillation)
0.07
Rule weight: 0.14
Evidence weight: 0.67
Similarity weight: 0.76
Evidence: 0.67
¬ Remarkable(amiodarone, be contraindicated in cardiogenic shock)
Evidence: 0.49
¬ Typical(warfarin, be used in atrial fibrillation)